Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study

Table 2 Dietary intake of different ω-3 polyunsaturated fatty acids by gender, median (25^th-75^th percentiles)

	Overall	Male	Female	P value1
ALA, 18:3 (n = 2316)	1.57 (1.05, 2.27)	1.75 (1.21, 2.48)	1.43 (0.93, 2.06)	< 0.001
SDA, 18:4 (n = 1720)	0.01 (0.00, 0.01)	0.00 (0.00, 0.01)	0.00 (0.00, 0.00)	< 0.001
EPA, 20:5 (n = 2252)	0.01 (0.00, 0.02)	0.01 (0.01, 0.02)	0.01 (0.00, 0.02)	< 0.001
DPA, 22:5 (n = 2278)	0.02 (0.01, 0.03)	0.02 (0.01, 0.04)	0.02 (0.01, 0.02)	< 0.001
DHA, 22:6 (n = 2225)	0.02 (0.01, 0.06)	0.03 (0.01, 0.07)	0.02 (0.01, 0.06)	0.001

¹P value was determined by analysis of variance.

ALA: α-Linolenic acid; SDA: Stearidonic acid; EPA: Eicosapentaenoic acid; DPA: Docosapentaenoic acid; DHA: Docosahexaenoic acid.